Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anaemia Response to the Treatment”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT00086086
What this trial is testing

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

Who this might be right for
Congestive Heart FailureAnemia
Amgen 150
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00776425
What this trial is testing

The Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 117
Testing effectiveness (Phase 2)Study completedNCT03030183
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 3
Not applicableEnded earlyNCT01736215
What this trial is testing

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Who this might be right for
Anemia - Cancer Related
Janssen-Cilag Ltd.,Thailand 33
Not applicableStudy completedNCT01964742
What this trial is testing

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

Who this might be right for
HIV-HCV Co-infected Patients
Assistance Publique Hopitaux De Marseille 68
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Post-approval studies (Phase 4)Ended earlyNCT02624141
What this trial is testing

Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Who this might be right for
Anemia
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT00210587
What this trial is testing

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Post-approval studies (Phase 4)Study completedNCT00283465
What this trial is testing

The Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Who this might be right for
AnemiaNeoplasm
Janssen-Cilag B.V. 316
Testing effectiveness (Phase 2)Study completedNCT03041909
What this trial is testing

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Who this might be right for
Sickle Cell Disease
Global Blood Therapeutics 5
Testing effectiveness (Phase 2)Ended earlyNCT05116774
What this trial is testing

BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
BioCryst Pharmaceuticals 12
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Testing effectiveness (Phase 2)Study completedNCT01977482
What this trial is testing

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

Who this might be right for
Anaemia
GlaxoSmithKline 216
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Large-scale testing (Phase 3)Study completedNCT00152490
What this trial is testing

Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Who this might be right for
Crohn's Disease
UCB Pharma 604
Post-approval studies (Phase 4)Active Not RecruitingNCT05891249
What this trial is testing

Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Who this might be right for
Anemia
Bristol-Myers Squibb 85
Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Post-approval studies (Phase 4)UnknownNCT02225886
What this trial is testing

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Who this might be right for
Anaemia Response to the TreatmentPeripheral Iron IndicesOxalemia
Anemia Working Group Romania 100
Next Page